E245-0151 Screening compound: N-(1-benzylpiperidin-4-yl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide

E245-0151 Screening compound: N-(1-benzylpiperidin-4-yl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
E245-0151 Screening compound: N-(1-benzylpiperidin-4-yl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E245-0151
N-(1-benzylpiperidin-4-yl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E245-0151

Molecular Formula

C20H23N3O4S (C20 H23 N3 O4 S)

Compound Name

N-(1-benzylpiperidin-4-yl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide

IUPAC name

N-(1-benzylpiperidin-4-yl)-3-oxo-34-dihydro-2H-14-benzoxazine-6-sulfonamide

SMILES

O=C1Nc(cc(cc2)S(NC3CCN(Cc4ccccc4)CC3)(=O)=O)c2OC1

InChI

InChI=1S/C20H23N3O4S/c24-20-14-27-19-7-6-17(12-18(19)21-20)28(25,26)22-16-8-10-23(11-9-16)13-15-4-2-1-3-5-15/h1-7,12,16,22H,8-11,13-14H2,(H,21,24)

InChI Key

SNOOIZQEDAMKIV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14852440

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

401.49

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

1.936

Distribution Coefficient, logD

0.874

Water Solubility, LogSw

-2.80

Polar Surface Area

78.746

Acid Dissociation Constant (pKa)

10.71

Base Dissociation Constant (pKb)

8.42

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

35.00

E245-0151 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anti-Aging Library (44940 compounds)

Glucocorticoid receptors Library (4806 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
  • Endocrine
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • Epigenetic
  • Receptor's ligands
Targets:
  • Nuclear receptors

References: we are preparing a list of scientific research reports with E245-0151 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E245-0151?
Check Price and Availability of E245-0151, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E245-0151 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E245-0151
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E245-0151
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E245-0151 available by request